Founder, SVP and CTO
Center for Pharma Crystallization, J-Star Research ½Porton Pharma Solutions
Dr. Jian Wang has 30 years of R&D experience in API crystallization, reaction and process engineering, and has been providing R&D services since 2005 to pharmaceutical clients around the globe. During her 11-year tenure at Merck since 1994, Jian became an expert in API process R&D and a champion in implementing science-based and technology-enabled approaches. She promoted the application of PAT tools in process R&D serving as a consultant at Mettler Toledo AutoChem during 2005-2010. In 2011-2013, Jian took the responsibility as VP of Crystallization Development at Crystal Pharmatech, helping a diverse client base in solving API crystallization problems. To better assist new drug development programs, Jian started up a state-of-the-art crystallization center at J-Star Research in the beginning of 2014 complementing its strong API Process Research. She now leads the Center for Pharma Crystallization at Porton Pharma solutions, mother company of J-Star Research, as Senior Vice President and CTO, addressing a wide range of challenges associated with API isolation from early to late developmental stages. Working closely with drug formulation experts, Jian also has been driving the establishment of API formulation services at J-Star that are well integrated with API crystallization R&D.
Jian received her Ph.D. degree in Chemical Engineering in 1994, from the University of Pittsburg with Prof. Donna Blackmond and Prof. Irving Winder. She has published 21 peer-reviewed articles and 6 patents. She taught for 5 years (2016-2021) in both USA and Europe on Controlled Crystallization of Organic Compounds, working with the Center for Professional Advancement. Her passion lies in both debottlenecking drug development via addressing crystallization related challenges and coaching young scientists in effective problem solving.